Shares of Health Care sector company Jazz Pharmaceuticals moved 1.5% today, and are now trading at a price of $107.55. The Mid-Cap stock's daily volume was 172,869 compared to its average volume of 824,037. The S&P 500 index returned a 0.0% performance.
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company is based in Dublin and has 2,800 full time employees. Its market capitalization is $6,523,854,336.
17 analysts are following Jazz Pharmaceuticals and have set target prices ranging from $145.0 to $230.0 per share. On average, they have given the company a rating of buy. At today's prices, JAZZ is trading -41.25% away from its average analyst target price of $183.06 per share.
Over the last year, JAZZ shares have gone down by -6.2%, which represents a difference of -25.5% when compared to the S&P 500. The stock's 52 week high is $148.06 per share and its 52 week low is $95.49. With average free cash flows of $1.01 Billion that have been growing at an average rate of 10.9% over the last 5 years, Jazz Pharmaceuticals declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 1,395,908 | 38,070 | 1,357,838 | 27.13 |
| 2023 | 1,092,007 | 23,962 | 1,068,045 | -14.07 |
| 2022 | 1,271,977 | 29,046 | 1,242,931 | 65.53 |
| 2021 | 778,507 | 27,641 | 750,866 | -15.12 |
| 2020 | 899,648 | 15,004 | 884,644 | 20.15 |
| 2019 | 776,401 | 40,135 | 736,266 |
